Effect of designations of index date in externally controlled trials: an empirical example

Author:

Van Le Hoa1,De Benedetti Marc1ORCID,Yue Lihua1,Fang Lorraine1,Van Naarden Braun Kim2,Lin Po-Chun3,Yang Yanhui1,Yang Ling1,Li Daniel4

Affiliation:

1. Global Biometrics and Data Sciences , Bristol Myers Squibb , Berkeley Heights , NJ , USA

2. Translational Epidemiology , Bristol Myers Squibb , Summit , NJ , USA

3. Global Biometrics and Data Sciences , Bristol Myers Squibb , Uxbridge , UK

4. Global Biometrics and Data Sciences , Bristol Myers Squibb Company , Seattle , WA , USA

Abstract

Abstract Objectives To create an external control arm (ECA) for a single arm trial, the choice of index date – when a patient becomes eligible for a study, is a complex issue. In real world data (RWD), patients commonly have multiple qualifying lines of therapy (LOT) which can be used to determine the index date. This study assessed the impact of different methods to assign the index date on the effectiveness estimates of the target drug versus conventional therapies and explored the impact of seven methods to assign the index date on the effectiveness estimates of the target drug versus conventional therapies. Methods A study using RWD was conducted in which patients received varied number of LOTs before qualifying for entry into the ECA. Two novel and five established indexing methods were examined for the ECA in this comparative effectiveness research. Baseline characteristics were adjusted by using stabilized inverse probability of treatment weighting (sIPTW). Cox proportional hazards (PH) model was used for time-to-event endpoints and risk ratio (RR) was estimated from a binomial regression for response-based end points. Results Five methods (first eligible line [FEL], restricted-line, all eligible lines, random line, and stratified random line) demonstrated close clinical outcome estimates after adjustment of baseline differences via sIPTW. The FEL resulted in an inability to adjust for number of prior LOTs due to poor overlap of line distribution in this study. The last and second last eligible line cannot be recommended due to their inability to adjust for immortal time bias. Conclusions Multiple methods are available for selecting the most appropriate index date for an ECA, and this empirical study has indicated that certain methods yield comparable outcomes when the treatment effect and sample size are large. It is important for researchers to carefully assess the specifics of their studies and justify their selection of the most appropriate indexing method. Future research including simulations to evaluate the two novel stratified random line and SLEL methods is necessary.

Publisher

Walter de Gruyter GmbH

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3